Back to today’s briefing

Story perspectives

Breakthrough Study Identifies Key Biomarkers for MASLD

9/26/2025

35 4

Summary

Story summary

Researchers used genetic tools and machine learning to identify biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD).
The study analyzed over 2,900 molecular and 35 clinical biomarkers, identifying six molecular and eight clinical MASLD markers.
Serum total protein (STP) partially mediates the HLA-A–MASLD link and strongly associates with MASLD risk; a machine learning model shows diagnostic accuracy.

1 of 1

Story summary

Researchers used genetic tools and machine learning to identify biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD).
The study analyzed over 2,900 molecular and 35 clinical biomarkers, identifying six molecular and eight clinical MASLD markers.
Serum total protein (STP) partially mediates the HLA-A–MASLD link and strongly associates with MASLD risk; a machine learning model shows diagnostic accuracy.